Pharma Focus Asia

Umoja Biopharma Opens New Manufacturing Facility in Louisville, Colorado, US


Umoja Biopharma, plans for the construction of new manufacturing facility. The new facility will be dedicated for the production of next-generation CAR T immunotherapies.


The state-of-the-art facility designed with 146,000 square foot will overcome the production barriers and delivers effective, accessible cancer treatments.

The new facility features house labs, offices, and manufacturing space for the production of lentiviral vector. In addition, it will further improve the vector manufacturing, process development, and formulation capabilities.

This investment in the new facility is committed to bring new therapies to cancer patients and also will be used for how these therapies are produced, stored, and distributed.

The construction of the manufacturing facility is expected to start its operation in first quarter of 2023.


NameUmoja Biopharma
TypeNew Construction
magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024